Have you ever filled a prescription, only to have the pharmacy tell you your copay just tripled? Or worse, that your medication is no longer covered at all? If you rely on Medicare Part D or private insurance, this scenario is becoming increasingly common. The landscape of prescription drug coverage has shifted dramatically, driven by new federal laws and aggressive cost-cutting measures by insurers. Understanding these shifts isn't just about saving money; it's about maintaining your health without unexpected financial shocks.
The core issue lies in Formulary updates. A formulary is simply the list of drugs your insurance plan agrees to cover. These lists are not static. Insurance providers and Pharmacy Benefit Managers (PBMs) regularly tweak them to control costs. For patients, these tweaks often mean being pushed toward cheaper alternatives, primarily Generic drugs and biosimilars. While generics save money, the transition can be confusing and sometimes disruptive if you aren't prepared.
Why Are Formularies Changing So Much?
You might wonder why your insurer keeps changing the rules. The biggest driver right now is the Inflation Reduction Act (IRA), signed into law in August 2022. This legislation fundamentally rewired how Medicare Part D plans operate. Before the IRA, plans had different incentives that often favored expensive brand-name drugs because they could earn rebates from manufacturers. The IRA flipped this model.
Now, plans are incentivized to steer patients toward lower-cost options like generics and biosimilars to manage their own bottom lines. Dr. Richard Mendelson, a Senior Healthcare Analyst at Milliman, noted that the IRA has "fundamentally altered plan incentives, shifting from rebate-driven coverage of high-cost brands to cost-containment through generics." This means insurers are actively looking for ways to substitute your current medication with a cheaper equivalent whenever possible.
Additionally, the market is consolidating. Three major PBMs-OptumRx, CVS Caremark, and Express Scripts-control roughly 84% of the market. When these giants decide to update their formularies, millions of people feel the impact simultaneously. In 2025, we saw CVS Caremark exclude nine specialty medications while adding eighteen others, including oncology biosimilars like Kanjinti and Trazimera. These moves are strategic, designed to leverage bulk purchasing power and push specific products.
Understanding the Cost Tiers
To navigate these changes, you need to understand how your plan categorizes drugs. Most plans use a tiered system that determines your out-of-pocket cost. Here is how the tiers typically break down based on 2025 data:
| Tier | Description | Average Copay |
|---|---|---|
| Tier 1 | Preferred Generics | $1 - $10 |
| Tier 2 | Non-Preferred Generics & Preferred Brands | ~$47 |
| Tier 3 | Non-Preferred Brands | ~$113 |
| Specialty | High-Cost Medications | $113 or 25% coinsurance |
When an insurer performs a Tier reassignment, they might move a drug you've taken for years from Tier 2 to Tier 3. Suddenly, your monthly bill jumps from $47 to over $100. This is a common tactic to encourage you to switch to a preferred generic or a different brand that the insurer has negotiated a better deal with. Conversely, the introduction of Biosimilars-biologic versions of generic drugs-can create opportunities for savings. For example, switching from Humira to its biosimilar Amjevita saved one user $450 monthly with no noticeable difference in effectiveness.
The Four Ways Your Coverage Can Change
Insurers don't just change prices; they change access. There are four primary mechanisms they use to alter your coverage:
- Complete Exclusions: The drug is removed from the formulary entirely. You must pay cash or switch medications.
- Tier Reassignments: The drug stays covered, but your cost share increases significantly.
- Prior Authorization (PA): Your doctor must prove to the insurer that you specifically need this drug before they will cover it. This adds administrative burden and potential delays.
- Step Therapy: Also known as "fail first," this requires you to try and fail on a cheaper alternative before the insurer will cover your preferred drug.
Scott Glovsky, a healthcare attorney, reported that "non-medical switching"-changes driven by insurer policy rather than medical necessity-increased by 23% year-over-year. This creates significant disruption for patients who were stable on their current regimen. If you find yourself facing a prior authorization requirement, don't panic. It's a bureaucratic hurdle, not necessarily a denial. However, it does require immediate action from your doctor's office.
How to Spot Changes Before They Hit You
Timing is everything. Insurers are legally required to give you advance notice if a formulary change affects a medication you are currently taking. Under CMS rules, you should receive at least 60 days' notice. For newly approved generics, this window may shrink to 30 days.
The best time to review your coverage is between October and December each year. This is when insurers send out their annual Summary of Benefits and Coverage (SOC) documents. Don't just skim these letters. Look specifically for sections titled "Formulary Changes" or "Drug List Updates." If you see your medication listed under "Excluded" or moved to a higher tier, mark your calendar to take action before January 1st.
If you miss the annual notice, check your online patient portal or call your pharmacy. Pharmacists are often the first to know about pending changes because they receive updated formulary files directly from PBMs. Building a relationship with your pharmacist can provide an early warning system that saves you hundreds of dollars.
Fighting Back: Exceptions and Appeals
What happens if your doctor insists you stay on your current brand-name drug, but your insurer wants you to switch? You have the right to request a Coverage exception. This is a formal request for your plan to cover a drug despite it not being on the formulary or being on a higher tier.
Here is how the process works:
- Contact Your Doctor: Explain the formulary change. Ask them to file a "Letter of Medical Necessity" stating why the generic or alternative won't work for you (e.g., past adverse reactions, clinical inefficacy).
- Submit the Request: Your doctor submits the exception request to the insurance plan. Standard requests are processed within 72 hours. If waiting would seriously harm your health, you can request an expedited review, which must be decided within 24 hours.
- Review the Decision: In 2024, CMS data showed an 82.3% approval rate for tiering exceptions. However, approvals for completely excluded drugs were much lower, at only 47.1%.
If your exception is denied, you have the right to appeal. Start with an internal appeal to the plan, then move to external review by an independent entity if necessary. Keep records of every communication. Cigna’s member survey revealed that while 73% of members successfully obtained exceptions, 38% experienced medication interruptions lasting 10-14 days while waiting for resolution. To mitigate this risk, ask your pharmacy for a transitional supply-a small amount of medication to bridge the gap while your exception is being processed. By law, many plans must provide a 30-day transitional supply for non-controlled substances during a plan change.
Looking Ahead: What to Expect in 2026 and Beyond
The trend toward generic and biosimilar substitution is accelerating. The Medicare Drug Price Negotiation Program (MDPNP), mandated by the IRA, will force all Part D plans to cover certain negotiated drugs starting January 1, 2026. Initial targets include Stelara, Prolia, and Xolair. This means these specific drugs will likely become preferred options, potentially pushing other competitors off the formulary or to higher tiers.
Biosimilar adoption is also skyrocketing. The FDA approved 17 biosimilars in 2024 alone, a 34% increase from the previous year. With FDA guidance evolving to support interchangeability even without specific designations, expect more automatic switches at the pharmacy counter. Dr. Janet Woodcock projects that biosimilar market penetration could reach 45% for targeted therapies by 2027.
For patients, this means staying vigilant. The era of "set it and forget it" prescriptions is ending. Active management of your drug coverage is now a essential part of healthcare maintenance. Review your benefits annually, talk to your pharmacist, and don't hesitate to fight for your medical needs through the appeals process.
What is a formulary update?
A formulary update is a change made by your insurance plan to the list of prescription drugs they cover. These updates can add new drugs, remove existing ones, or change the cost-sharing tier (your copay) for specific medications. They usually happen annually but can occur mid-year for newly approved drugs.
How do I know if my medication is still covered?
You should receive an annual letter from your insurer detailing formulary changes. Additionally, you can log into your insurance provider's website or app to search their current formulary. Your pharmacist can also check coverage status when you fill your prescription.
What is a coverage exception?
A coverage exception is a request to your insurance plan to cover a drug that is not on their formulary or to waive certain restrictions like step therapy. Your doctor must submit medical documentation proving that the requested drug is medically necessary for your condition.
Can my pharmacy automatically switch me to a generic?
Yes, in most cases. Unless your doctor specifies "Dispense as Written" or "Brand Medically Necessary" on the prescription, pharmacists are allowed to substitute a generic version if one is available and approved by the FDA. This is known as generic substitution.
What is the difference between a generic and a biosimilar?
Generics are chemically identical copies of small-molecule brand drugs. Biosimilars are highly similar versions of biologic drugs, which are larger, more complex molecules made from living cells. While generics are exact copies, biosimilars allow for minor differences but must demonstrate no clinically meaningful differences in safety or efficacy.
How long does it take to get a formulary exception approved?
Standard exception requests are typically processed within 72 hours. If you qualify for an expedited review due to urgent medical needs, the decision must be made within 24 hours. Delays can occur if additional information is requested from your doctor.
What is step therapy?
Step therapy, or "fail first," is a utilization management tool where insurance requires you to try one or more lower-cost medications before they will approve coverage for the drug your doctor prescribed. You must demonstrate that the cheaper options did not work or caused side effects.
Does the Inflation Reduction Act affect my drug costs?
Yes. Starting in 2025, the IRA implemented a $2,000 annual out-of-pocket cap for Medicare Part D beneficiaries. It also eliminated the "donut hole" coverage gap, providing continuous coverage until you hit the catastrophic threshold. Future provisions will also mandate coverage for negotiated-price drugs.
